Initial benefit of TAVR remains consistent over the first three years among patients at low surgical risk

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly lower, following the TAVR procedure compared with patients who received conventional surgical aortic valve replacement (SAVR), according to new data being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Related Keywords

New Zealand ,Australia ,Japan ,United States ,Netherlands ,New Haven ,Connecticut ,Canada ,France ,Yale University ,American ,Johnk Forrest ,Emily Henderson ,Journal Of The American College Cardiology ,Yale University School Of Medicine ,Medtronic ,American College ,Annual Scientific Session Together With ,World Congress ,Yale University School ,American Heart Association Guideline ,Patients With Valvular Heart Disease ,Evolut Low Risk Trial ,New England Journal ,Aorta ,Aortic Stenosis ,Flood ,Calcium ,Ardiology ,Heart ,Heart Disease ,Hospital ,Interventional Cardiology ,Medicine ,Pacemaker ,Estenosis ,Stroke ,Surgery ,Transcatheter Aortic Valve Replacement ,